- $1.84bn
- $1.82bn
- $105.97m
Brief: Zymeworks Said To Near $929 Million Deal For Theravance - Bloomberg News
Brief: Zymeworks Announces Share Repurchase Program Of Up To $125 Million Of Its Common Stock
Canada's Zymeworks Q1 revenue misses estimates on absence of prior milestone payments
U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences
Zymeworks rises after naming new CFO
U.S. STOCKS ON THE MOVE-Intel, Tempus AI, Boeing
U.S. STOCKS ON THE MOVE-Cal-Maine, Rivian, Alkermes
U.S. STOCKS ON THE MOVE-Seagate, nCino, Zymeworks
Zymeworks rises after naming new CFO
U.S. STOCKS ON THE MOVE-Sysco, Crowdstrike, GM
U.S. STOCKS ON THE MOVE-Agnico Eagle Mines, ProPetro, Kezar
U.S. STOCKS ON THE MOVE-Insmed, United Therapeutics, CrowdStrike
U.S. STOCKS ON THE MOVE-Energy shares, miners, Sysco
Zymeworks rises as ovarian cancer drug gets FDA fast-track status
Brief: Zymeworks And Royalty Pharma Enter Into $250 Million Royalty-Backed Note Financing
Canada's Zymeworks 2025 revenue rises 39%
U.S. STOCKS ON THE MOVE-AbCellera Biologics, Zymeworks, Silver miners
Zymeworks rises after unveiling leadership changes
Brief: Zymeworks Outlines Strategic Priorities And Outlook For 2026